| # | Title | Journal | Year | Citations |
|---|
| 1 | The St George's Respiratory Questionnaire | Respiratory Medicine | 1991 | 1,743 |
| 2 | Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire | Respiratory Medicine | 2006 | 795 |
| 3 | Inhaler mishandling remains common in real life and is associated with reduced disease control | Respiratory Medicine | 2011 | 769 |
| 4 | Measurement properties and interpretation of three shortened versions of the asthma control questionnaire | Respiratory Medicine | 2005 | 725 |
| 5 | Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children | Respiratory Medicine | 1994 | 700 |
| 6 | Research in high flow therapy: Mechanisms of action | Respiratory Medicine | 2009 | 622 |
| 7 | Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD | Respiratory Medicine | 2008 | 503 |
| 8 | The role of mast cells in allergic inflammation | Respiratory Medicine | 2012 | 501 |
| 9 | Not 15 But 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies | Respiratory Medicine | 2003 | 494 |
| 10 | Pulse oximetry: Understanding its basic principles facilitates appreciation of its limitations | Respiratory Medicine | 2013 | 449 |
| 11 | The history of tuberculosis | Respiratory Medicine | 2006 | 441 |
| 12 | Anxiety and depression in COPD patients: The roles of gender and disease severity | Respiratory Medicine | 2006 | 388 |
| 13 | Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD | Respiratory Medicine | 2013 | 384 |
| 14 | Chylothorax: Aetiology, diagnosis and therapeutic options | Respiratory Medicine | 2010 | 365 |
| 15 | Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial | Respiratory Medicine | 2003 | 362 |
| 16 | Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials | Respiratory Medicine | 2016 | 335 |
| 17 | Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort | Respiratory Medicine | 2013 | 328 |
| 18 | How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? | Respiratory Medicine | 2005 | 324 |
| 19 | Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine | Respiratory Medicine | 2003 | 323 |
| 20 | Physical inactivity in patients with COPD, a controlled multi-center pilot-study | Respiratory Medicine | 2010 | 303 |
| 21 | Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) | Respiratory Medicine | 2020 | 303 |
| 22 | The discovery of α1-antitrypsin and its role in health and disease | Respiratory Medicine | 2011 | 294 |
| 23 | Inhaler competence in asthma: Common errors, barriers to use and recommended solutions | Respiratory Medicine | 2013 | 289 |
| 24 | The human pharmacology of fluticasone propionate | Respiratory Medicine | 1990 | 286 |
| 25 | Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study | Respiratory Medicine | 2006 | 283 |
| 26 | Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis | Respiratory Medicine | 2008 | 280 |
| 27 | Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease | Respiratory Medicine | 2000 | 277 |
| 28 | Systemic side effects of inhaled corticosteroids in patients with asthma | Respiratory Medicine | 2006 | 277 |
| 29 | Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment | Respiratory Medicine | 2006 | 274 |
| 30 | Evolution of dry powder inhaler design, formulation, and performance | Respiratory Medicine | 2002 | 271 |
| 31 | Guidelines for the measurement of respiratory function | Respiratory Medicine | 1994 | 267 |
| 32 | The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK | Respiratory Medicine | 2007 | 266 |
| 33 | Predicting and evaluating response to omalizumab in patients with severe allergic asthma | Respiratory Medicine | 2007 | 262 |
| 34 | Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients | Respiratory Medicine | 2009 | 262 |
| 35 | The costs of exacerbations in chronic obstructive pulmonary disease (COPD) | Respiratory Medicine | 2002 | 259 |
| 36 | Inflammation and immunity in IPF pathogenesis and treatment | Respiratory Medicine | 2019 | 259 |
| 37 | Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol | Respiratory Medicine | 1994 | 258 |
| 38 | Sex differences in the incidence and severity of respiratory tract infections | Respiratory Medicine | 2007 | 257 |
| 39 | Importance of inhaler devices in the management of airway disease | Respiratory Medicine | 2008 | 256 |
| 40 | Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections | Respiratory Medicine | 2009 | 256 |
| 41 | Reference values for the 6-min walk test in healthy subjects 20–50 years old | Respiratory Medicine | 2006 | 253 |
| 42 | A daily SMS reminder increases adherence to asthma treatment: A three-month follow-up study | Respiratory Medicine | 2010 | 252 |
| 43 | Aetiology in adult patients with bronchiectasis | Respiratory Medicine | 2007 | 250 |
| 44 | Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma | Respiratory Medicine | 2007 | 250 |
| 45 | Six minute walk distance in healthy subjects aged 55–75 years | Respiratory Medicine | 2006 | 247 |
| 46 | Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL) | Respiratory Medicine | 2000 | 246 |
| 47 | Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking | Respiratory Medicine | 2006 | 243 |
| 48 | Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients | Respiratory Medicine | 2004 | 242 |
| 49 | Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology | Respiratory Medicine | 2017 | 242 |
| 50 | Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs | Respiratory Medicine | 2011 | 240 |
